Chargement en cours...
The Effect of Drotrecogin Alfa (activated) on Long-Term Survival after Severe Sepsis
OBJECTIVE: To determine long-term survival for subjects with severe sepsis enrolled in the previous multicenter trial (PROWESS) of drotrecogin alfa (activated) [DrotAA] versus placebo. DESIGN: Retrospective, cross-sectional, blinded follow-up of subjects enrolled in a previous randomized, controlled...
Enregistré dans:
| Publié dans: | Crit Care Med |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2004
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4714718/ https://ncbi.nlm.nih.gov/pubmed/15640631 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|